Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ECM Therapeutics receives FDA 510(k) clearance for ECMT-100 WMD, validating its extracellular matrix hydrogel platform.
-
Applied Biologics completes enrollment in the CAMPX RCT evaluating XWRAP® for chronic diabetic foot ulcers across 23 SerenaGroup sites.
-
XWRAP showed statistically significant wound closure improvement vs. standard of care alone in the CAMPX RCT — 31% vs. 18% (ITT, p=0.023).
-
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
-
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
-
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
-
BioStem Technologies Reports First Quarter 2026 Financial Results
-
WINNIPEG, Manitoba, May 13, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announced today its participation in the World Council of Enterostomal...
-
Sanuwave Announces Revenues and Financial Results for Q1 FY2026
-
BioStem Technologies to Present at the 16th Annual LD Micro Invitational